| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 5.68e-06 | 3 | 28 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.71e-04 | 14 | 28 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.86e-04 | 18 | 28 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.60e-04 | 31 | 28 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.75e-04 | 33 | 28 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | cyclin binding | 1.10e-03 | 35 | 28 | 2 | GO:0030332 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 6.65e-05 | 9 | 29 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.01e-04 | 11 | 29 | 2 | GO:0031094 | |
| MousePheno | impaired glucose tolerance | 1.51e-05 | 480 | 25 | 7 | MP:0005293 | |
| MousePheno | small pancreatic islets | 7.29e-05 | 46 | 25 | 3 | MP:0009172 | |
| MousePheno | absent somatotrophs | 1.10e-04 | 9 | 25 | 2 | MP:0008330 | |
| MousePheno | abnormal enteroendocrine cell morphology | 2.76e-04 | 14 | 25 | 2 | MP:0004141 | |
| MousePheno | intermingled spleen red and white pulp | 3.18e-04 | 15 | 25 | 2 | MP:0008475 | |
| MousePheno | abnormal pancreatic islet morphology | 3.34e-04 | 190 | 25 | 4 | MP:0005215 | |
| MousePheno | abnormal endocrine pancreas morphology | 3.41e-04 | 191 | 25 | 4 | MP:0009165 | |
| MousePheno | abnormal glucose tolerance | 3.43e-04 | 787 | 25 | 7 | MP:0005291 | |
| MousePheno | decreased adrenocorticotropin level | 4.62e-04 | 18 | 25 | 2 | MP:0005128 | |
| MousePheno | abnormal pancreatic islet size | 5.18e-04 | 89 | 25 | 3 | MP:0009170 | |
| MousePheno | reduced fertility | 5.25e-04 | 844 | 25 | 7 | MP:0001921 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 5.33e-04 | 1124 | 25 | 8 | MP:0011112 | |
| MousePheno | abnormal endocrine gland morphology | 6.00e-04 | 1144 | 25 | 8 | MP:0013560 | |
| MousePheno | decreased somatotroph cell number | 6.32e-04 | 21 | 25 | 2 | MP:0008329 | |
| Domain | InsP3_rcpt-bd | 6.98e-06 | 3 | 29 | 2 | IPR000493 | |
| Domain | RIH_assoc | 3.48e-05 | 6 | 29 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.48e-05 | 6 | 29 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 3.48e-05 | 6 | 29 | 2 | PF01365 | |
| Domain | RIH_dom | 3.48e-05 | 6 | 29 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.48e-05 | 6 | 29 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.48e-05 | 6 | 29 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 3.48e-05 | 6 | 29 | 2 | PF08709 | |
| Domain | - | 3.48e-05 | 6 | 29 | 2 | 1.25.10.30 | |
| Domain | TPR_8 | 7.48e-05 | 53 | 29 | 3 | PF13181 | |
| Domain | MIR | 1.04e-04 | 10 | 29 | 2 | PS50919 | |
| Domain | MIR | 1.04e-04 | 10 | 29 | 2 | PF02815 | |
| Domain | MIR | 1.04e-04 | 10 | 29 | 2 | SM00472 | |
| Domain | MIR_motif | 1.04e-04 | 10 | 29 | 2 | IPR016093 | |
| Domain | zf-CCHC | 5.77e-04 | 23 | 29 | 2 | PF00098 | |
| Domain | - | 7.39e-04 | 26 | 29 | 2 | 4.10.60.10 | |
| Domain | TPR | 1.03e-03 | 129 | 29 | 3 | SM00028 | |
| Domain | TPR_repeat | 1.13e-03 | 133 | 29 | 3 | IPR019734 | |
| Domain | ZF_CCHC | 1.34e-03 | 35 | 29 | 2 | PS50158 | |
| Domain | TPR-contain_dom | 1.59e-03 | 150 | 29 | 3 | IPR013026 | |
| Domain | TPR | 2.09e-03 | 165 | 29 | 3 | PS50005 | |
| Domain | TPR_REGION | 2.09e-03 | 165 | 29 | 3 | PS50293 | |
| Domain | ZnF_C2HC | 3.29e-03 | 55 | 29 | 2 | SM00343 | |
| Domain | Znf_CCHC | 3.29e-03 | 55 | 29 | 2 | IPR001878 | |
| Domain | - | 3.96e-03 | 207 | 29 | 3 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 5.51e-03 | 233 | 29 | 3 | IPR011990 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.26e-05 | 5 | 26 | 2 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 4.88e-05 | 6 | 26 | 2 | M47960 | |
| Pathway | SIG_CHEMOTAXIS | 7.51e-05 | 45 | 26 | 3 | M5193 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.17e-04 | 9 | 26 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.46e-04 | 10 | 26 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.78e-04 | 11 | 26 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.78e-04 | 11 | 26 | 2 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.52e-04 | 13 | 26 | 2 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.52e-04 | 13 | 26 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.52e-04 | 13 | 26 | 2 | M47696 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.52e-04 | 13 | 26 | 2 | MM14553 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.86e-04 | 16 | 26 | 2 | M26945 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.49e-04 | 19 | 26 | 2 | M47760 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 5.49e-04 | 19 | 26 | 2 | M27423 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 5.49e-04 | 19 | 26 | 2 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 6.09e-04 | 20 | 26 | 2 | M47688 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 6.09e-04 | 20 | 26 | 2 | MM15070 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.72e-04 | 21 | 26 | 2 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.39e-04 | 22 | 26 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.39e-04 | 22 | 26 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.08e-04 | 23 | 26 | 2 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 9.56e-04 | 25 | 26 | 2 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.12e-03 | 27 | 26 | 2 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.12e-03 | 27 | 26 | 2 | MM15053 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.20e-03 | 115 | 26 | 3 | M9387 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.20e-03 | 28 | 26 | 2 | M924 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.57e-03 | 32 | 26 | 2 | MM14983 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.71e-03 | 130 | 26 | 3 | M27454 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.98e-03 | 36 | 26 | 2 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.98e-03 | 36 | 26 | 2 | M39831 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.57e-03 | 41 | 26 | 2 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.69e-03 | 42 | 26 | 2 | M791 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.69e-03 | 42 | 26 | 2 | M17541 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 2.95e-03 | 44 | 26 | 2 | M39845 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 3.22e-03 | 46 | 26 | 2 | M8626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.79e-03 | 50 | 26 | 2 | M47951 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.16e-03 | 178 | 26 | 3 | M2890 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 4.25e-03 | 53 | 26 | 2 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.41e-03 | 54 | 26 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.41e-03 | 54 | 26 | 2 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 4.41e-03 | 54 | 26 | 2 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 4.57e-03 | 55 | 26 | 2 | M47952 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.60e-03 | 61 | 26 | 2 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 5.78e-03 | 62 | 26 | 2 | M27321 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 5.96e-03 | 63 | 26 | 2 | MM15613 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.99e-03 | 203 | 26 | 3 | M5485 | |
| Pubmed | Phylogenetic and molecular characterization of the splicing factor RBM4. | 6.71e-07 | 2 | 29 | 2 | 23527094 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 6.71e-07 | 2 | 29 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 6.71e-07 | 2 | 29 | 2 | 17496801 | |
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 6.71e-07 | 2 | 29 | 2 | 16195467 | |
| Pubmed | The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum. | 6.71e-07 | 2 | 29 | 2 | 18708123 | |
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 6.71e-07 | 2 | 29 | 2 | 24901844 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15632133 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 33854148 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 15713744 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 19528657 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 8063813 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 6.71e-07 | 2 | 29 | 2 | 8081734 | |
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 2.01e-06 | 3 | 29 | 2 | 21435446 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 31979185 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 10874040 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.01e-06 | 3 | 29 | 2 | 24904548 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20395455 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17327232 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17437169 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 16014380 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18194433 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 27821480 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17890015 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18547250 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.01e-06 | 3 | 29 | 2 | 27777977 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 11413485 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.01e-06 | 3 | 29 | 2 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.01e-06 | 3 | 29 | 2 | 9858485 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.01e-06 | 3 | 29 | 2 | 17581770 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20427533 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.01e-06 | 3 | 29 | 2 | 18241669 | |
| Pubmed | A novel splicing regulator shares a nuclear import pathway with SR proteins. | 2.01e-06 | 3 | 29 | 2 | 12628928 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.01e-06 | 3 | 29 | 2 | 1693919 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 19068129 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23955339 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 25215520 | ||
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 4.02e-06 | 4 | 29 | 2 | 17925404 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 4.02e-06 | 4 | 29 | 2 | 21424589 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 28419336 | ||
| Pubmed | IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. | 4.02e-06 | 4 | 29 | 2 | 26193638 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 4.02e-06 | 4 | 29 | 2 | 35494252 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 28615414 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 10828023 | ||
| Pubmed | 6.29e-06 | 43 | 29 | 3 | 24227653 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 6.70e-06 | 5 | 29 | 2 | 21568942 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 21436055 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.00e-05 | 6 | 29 | 2 | 21762810 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.00e-05 | 6 | 29 | 2 | 16844763 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.00e-05 | 6 | 29 | 2 | 25966694 | |
| Pubmed | RBM4 promotes neuronal differentiation and neurite outgrowth by modulating Numb isoform expression. | 1.00e-05 | 6 | 29 | 2 | 27009199 | |
| Pubmed | LARK activates posttranscriptional expression of an essential mammalian clock protein, PERIOD1. | 1.41e-05 | 7 | 29 | 2 | 17264215 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 1.41e-05 | 7 | 29 | 2 | 22495310 | |
| Pubmed | 1.86e-05 | 686 | 29 | 6 | 28380382 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.87e-05 | 8 | 29 | 2 | 19033399 | |
| Pubmed | Activation of TrkB signaling mitigates cerebellar anomalies caused by Rbm4-Bdnf deficiency. | 2.41e-05 | 9 | 29 | 2 | 37670183 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 3.68e-05 | 11 | 29 | 2 | 27514653 | |
| Pubmed | RBM4 Modulates Radial Migration via Alternative Splicing of Dab1 during Cortex Development. | 4.41e-05 | 12 | 29 | 2 | 29581187 | |
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 34630045 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 7.00e-05 | 15 | 29 | 2 | 28578927 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 22115758 | ||
| Pubmed | RBM4 promotes pancreas cell differentiation and insulin expression. | 9.06e-05 | 17 | 29 | 2 | 23129807 | |
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 11696558 | ||
| Pubmed | 1.68e-04 | 23 | 29 | 2 | 22817342 | ||
| Pubmed | 1.83e-04 | 24 | 29 | 2 | 10843712 | ||
| Pubmed | 2.25e-04 | 142 | 29 | 3 | 30809309 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.65e-04 | 150 | 29 | 3 | 30154076 | |
| Pubmed | 2.69e-04 | 29 | 29 | 2 | 32123907 | ||
| Pubmed | Casein kinase 1α is required to maintain murine hypothalamic pro-opiomelanocortin expression. | 3.08e-04 | 31 | 29 | 2 | 37168577 | |
| Pubmed | 3.49e-04 | 33 | 29 | 2 | 16951258 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.02e-04 | 1201 | 29 | 6 | 35696571 | |
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 20510229 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.63e-04 | 38 | 29 | 2 | 30786075 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 5.89e-04 | 468 | 29 | 4 | 31056421 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 7.77e-04 | 217 | 29 | 3 | 31685992 | |
| Cytoband | 11q13 | 2.54e-03 | 118 | 29 | 2 | 11q13 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 3.85e-06 | 3 | 21 | 2 | 297 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 3.79e-04 | 25 | 21 | 2 | 74 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.78e-03 | 115 | 21 | 2 | 769 | |
| GeneFamily | RNA binding motif containing | 2.50e-02 | 213 | 21 | 2 | 725 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 9.37e-06 | 262 | 29 | 5 | M11472 | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 1.48e-04 | 159 | 29 | 3 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 1.51e-04 | 160 | 29 | 3 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.90e-04 | 173 | 29 | 3 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-04 | 179 | 29 | 3 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.10e-04 | 179 | 29 | 3 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 2.10e-04 | 179 | 29 | 3 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 183 | 29 | 3 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 184 | 29 | 3 | 840fac463665ed18752f402f7d1ef2e5052bdf74 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.27e-04 | 184 | 29 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 188 | 29 | 3 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.54e-04 | 191 | 29 | 3 | 146cfd4daa2878536b4f381564c787919ad855a8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.54e-04 | 191 | 29 | 3 | 12ea07565dc0e62cade9fbab4a2d763e47a341e3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 191 | 29 | 3 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.58e-04 | 192 | 29 | 3 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-04 | 192 | 29 | 3 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 193 | 29 | 3 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 193 | 29 | 3 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 193 | 29 | 3 | 25b1e5a04724023918c8939109a92b35582d5e5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 194 | 29 | 3 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-04 | 195 | 29 | 3 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-04 | 195 | 29 | 3 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-04 | 195 | 29 | 3 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-04 | 196 | 29 | 3 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 196 | 29 | 3 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.74e-04 | 196 | 29 | 3 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOpos|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.74e-04 | 196 | 29 | 3 | a4c9f46ff75dbdd43ad369ceda604fb1650d8a9a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-04 | 197 | 29 | 3 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | 343B-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 197 | 29 | 3 | 1b6f7a62b7fcfd55c25c5840353eed7183050860 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 2.78e-04 | 197 | 29 | 3 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | MNPs-Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 2.78e-04 | 197 | 29 | 3 | 03d74643646dce5d3a278a1ee48c390d13a7889c | |
| ToppCell | LAM-Myeloid-Macrophage|Myeloid / Condition, Lineage and Cell class | 2.78e-04 | 197 | 29 | 3 | 355fe286609df2ded973952f1856bbc5f437cfd0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-04 | 197 | 29 | 3 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | normal_Lung-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.82e-04 | 198 | 29 | 3 | 189b787d51985b13d645bdb64def2de0a214d55b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 3dafa555bd01e6d4b5ffbcdd542d738905140801 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 768df928a3265dbe7cce2acea07b2f6d6b709642 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.82e-04 | 198 | 29 | 3 | 77f41f0e0895b7c732bab1fd2e047f2ed31cbd9d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 198 | 29 | 3 | 1774dd36315a04c4cdcef2cc674204e4ab9c175b | |
| ToppCell | cellseq-Immune-Immune_Myeloid-AM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.86e-04 | 199 | 29 | 3 | 298302123a2b3815ed98130fa1a229e56e8ab77b | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-AM-AM|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.86e-04 | 199 | 29 | 3 | 255cf629351f35e516a5271d8758c29168ebd0cf | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 2.86e-04 | 199 | 29 | 3 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-04 | 199 | 29 | 3 | eeb936e52b0ae2e326b425a2c02be38aa62aece4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-04 | 199 | 29 | 3 | 03a3303d53005cf056bdd4971c393f20f980a201 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-04 | 199 | 29 | 3 | ad2681b71fdf9644c9e639fca4beb9be37e27638 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.90e-04 | 200 | 29 | 3 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION | |
| Drug | adenophostin A | 1.57e-06 | 2 | 29 | 2 | ctd:C085029 | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 4.74e-06 | 198 | 29 | 5 | 950_DN | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 6.12e-05 | 12 | 29 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 3.72e-04 | 29 | 29 | 2 | DOID:11984 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 4.54e-04 | 32 | 29 | 2 | DOID:332 (is_implicated_in) | |
| Disease | glucose measurement | 4.98e-04 | 380 | 29 | 4 | EFO_0004468 | |
| Disease | drug dependence | 5.44e-04 | 35 | 29 | 2 | EFO_0003890 | |
| Disease | obesity (implicated_via_orthology) | 1.21e-03 | 215 | 29 | 3 | DOID:9970 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HHLQGCLDALGHYKQ | 436 | Q969Y2 | |
| SHNHDALLKNYGLLH | 181 | Q14406 | |
| HNHYQKQLEIAHEKL | 291 | P30533 | |
| KVLLQAHNHHYKHLG | 61 | P16260 | |
| AIRNLHHYKLHGVNI | 51 | Q9BWF3 | |
| QNHHIIENNHILYLG | 541 | Q8IXQ6 | |
| HNIYILAHQLARHNK | 2106 | Q14571 | |
| GNQALLHKHLHLFLT | 1241 | Q14573 | |
| GSSVHNILHIKQLYH | 286 | Q5VXI9 | |
| LGNEHQHLYAKILHL | 1231 | Q96PY6 | |
| QLLLEKFLQHHSHLF | 1811 | Q4ZG55 | |
| NHLKEYHIKHDILNF | 591 | Q92831 | |
| HKHLQLLLPHATDIY | 1016 | Q15751 | |
| YLHQHYILHLDLKPE | 626 | Q32MK0 | |
| HYLGLSHHLLALNFI | 51 | Q6PIU2 | |
| LVLLAYFIGLKHHHA | 391 | P13473 | |
| AIRNLHHYKLHGVNI | 51 | Q9BQ04 | |
| YRHPGHIHKLLAQQL | 306 | Q8IVS2 | |
| LFRDIGHHLIHNNKI | 381 | Q5T0N1 | |
| LIRVEKQYLHHNLDH | 211 | Q8J025 | |
| KQYLHHNLDHLVEEL | 216 | Q8J025 | |
| YLRKHLLAHHQALQA | 381 | Q01101 | |
| HIGHAKAALLNQHYQ | 211 | P07814 | |
| SHQLDHSKLLGYLKH | 96 | Q07960 | |
| HLRYAHHLLLVKGQV | 276 | Q14190 | |
| GFTQLAHLQKHYLVH | 611 | O75626 | |
| LHQLGLIHLAIHYYQ | 821 | Q9Y5Q9 | |
| ALQHQHQYLELAHSL | 86 | Q96HA7 | |
| GKIFNQHILLTDHIH | 241 | Q8N859 | |
| IGSLENHYLFKHKNH | 61 | P29120 |